Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial
role in the prevention of cervical cancer, including recently announced elimination efforts …

Cervical cancer is the fourth most common cancer among women globally, with an
estimated 570 000 new cases and 311 000 deaths worldwide in 2018. 1–3 The highest …

Abstract Background The World Health Organization (WHO) called for global action towards
the elimination of cervical cancer. One of the main strategies is to screen 70% of women at …

In human papillomavirus (HPV) cervical cancer screening, cytology is used as triage to
counter the low specificity of HPV testing. VALID‐SCREEN is a EU‐multicenter …

Background: To date, the impact of the human papillomavirus (HPV) vaccine on invasive
cervical cancers in the United States has not been documented due, in part, to the time …

Objective TIGIT/CD155 has attracted widespread attention as a new immune checkpoint and
a potential target for cancer immunotherapy. In our study, we evaluated the role of …

Objective: The likelihood of timely treatment for cervical cancer increases with timely
detection of abnormal cervical cells. Automated methods of detecting abnormal cervical cells …

In May 2018, the World Health Organization (WHO) called for the elimination of cervical
cancer. To monitor this initiative, we examined cervical cancer incidence and mortality in the …

Background An estimated 570,000 women were diagnosed with cervical cancer worldwide,
and about 311,000 women died from the disease. Cervical cancer is possibly the most …